Global Healthcare Currency Hedged ETF

DRUG

Global Healthcare Currency Hedged ETF

DRUG

Invest in a portfolio of the world's leading healthcare companies

Invest with us Factsheet Info pack
NAV/unit
$9.38 As at 21 October 2026
Management fee and costs (p.a.)
0.57%
1 year performance
17.18% As at 30 September 2026
5 year performance (p.a.)
5.12% As at 30 September 2026
Category
Global shares
Secondary category(s)
Currency hedged, Sector & regions
Loading
Info Pack
close

Overview

Fund Objective

DRUG aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.

Benefits

Healthcare - a global growth opportunity

Ageing populations, rising living standards and ongoing medical advancements are expected to support increasing ongoing demand for healthcare products and services.

Cost-effective

Passive, index-tracking approach means no 'active manager' fees, making DRUG a cost-effective investment for those seeking exposure to the global healthcare sector.

Simple access to global healthcare giants

Access a diversified portfolio of the world's leading healthcare companies, such as Johnson & Johnson, Pfizer and Roche, in one trade.

There are risks associated with an investment in DRUG, including market risk, international investment risk, healthcare sector risk and concentration risk. Investment value can go up and down. An investment in the Fund should only be considered as a part of a broader portfolio, taking into account your particular circumstances, including your tolerance for risk. For more information on risks and other features of the Fund, please see the Product Disclosure Statement and Target Market Determination, both available on www.betashares.com.au.

Invest in DRUG with Betashares Direct

Invest in DRUG brokerage-free with a Betashares Direct account. You can also buy or sell DRUG using an online broker or your financial adviser.

Invest with us

Refer to the PDS for information on interest retained by Betashares on cash balances.

Key facts

Profile

Units outstanding* (#) 19,570,455
Management fee and cost** (p.a.) 0.57%
Distribution frequency Semi-annual
Distribution reinvestment plan (DRP) Full or partial participation available
Issuer Betashares Capital Ltd
Registry MUFG Corporate Markets
Domicile Australia

* As at 21 October 2026

**Certain additional costs apply. Please refer to PDS.

Net assets*

$183,525,582

Pricing information

Current price

Last trade*

% Change (prev day)

Bid (delayed)

Offer (delayed)

* Data is delayed by at least 20 minutes.

NAV

NAV/Unit*

$9.38

* As at 21 October 2026

Download NAV history

Past performance is not indicative of future performance. Please refer to “Fund returns after fees” for additional information regarding performance/return information.

Trading information

ASX code

DRUG

Bloomberg code

DRUG AU

IRESS code

DRUG.AXW

Market makers

Susquehanna Pacific Pty Ltd

Index information

Index

Nasdaq Global ex-Australia Healthcare AUD Hedged Index

Index provider

Nasdaq

Bloomberg index ticker

NQXAUHHN Index

Download index methodology

Performance

Fund returns after fees (%)

Fund Index
1 month -1.09% -1.10%
3 months 3.95% 4.06%
6 months 9.35% 9.77%
1 year 17.18% 17.92%
3 year p.a. 7.31% 7.84%
5 year p.a. 5.12% 5.59%
10 year p.a. 8.20% 8.61%
Since inception p.a. 7.66% 8.05%
Inception date 4-Aug-16 -
21 October 2026
Total Return: —

* As at 30 September 2026.

Past performance is not an indicator of future performance. Returns are calculated in Australian dollars using net asset value per unit at the start and end of the specified period and do not reflect brokerage or the bid ask spread that investors incur when buying and selling units on the ASX. Returns are after fund management costs, assume reinvestment of any distributions and do not take into account tax paid as an investor in the Fund. Returns for periods longer than one year are annualised. Current performance may be higher or lower than the performance shown.

Holdings and allocation

Portfolio holdings

Name Weight (%)
ELI LILLY & CO 8.5
JOHNSON & JOHNSON 7.5
ABBVIE INC 7.0
UNITEDHEALTH GROUP INC 5.2
MERCK & CO INC 5.1
ROCHE HOLDING AG 4.2
ASTRAZENECA PLC 4.0
NOVARTIS AG 3.9
THERMO FISHER SCIENTIFIC INC 3.9
AMGEN INC 3.2

* As at 21 October 2026. Excludes cash

Sector allocation

Pharmaceuticals
48.2%
Biotechnology
19.7%
Health Care Equipment
11.1%
Life Sciences Tools & Services
9.4%
Managed Health Care
6.8%
Health Care Supplies
1.8%
Health Care Facilities
1.3%
Health Care Services
1.1%
Health Care Technology
0.6%
Other
0.0%

* As of 30 September 2026

Country allocation

United States
80.7%
Switzerland
5.8%
Britain
4.1%
Japan
3.0%
Denmark
2.1%
China
0.9%
France
0.9%
Netherlands
0.9%
Germany
0.8%
Other
0.7%

* As of 30 September 2026

Distributions

Yield information

Distribution frequency Semi-annual
12 mth distribution yield* 3.9%

*As at 30 September 2026. Yield is calculated by summing the prior 12-month per unit distributions divided by the closing NAV per unit at the end of the relevant period. Yield will vary and may be lower at time of investment. Franking level is total franking level over the last 12 months. Past performance is not indicative of future performance.

You can elect DRP by logging into MUFG's Investor Centre. Once you are logged in, please proceed to the 'Payments and Tax' tab and select 'Reinvestment Plans'.

Recent distributions

Ex Date Record Date Payment Date Distribution Unit ($) Annual Distribution Return (%)1
1-Jul-26 2-Jul-26 16-Jul-26 $0.312119 4.50%
2-Jan-26 5-Jan-26 19-Jan-26 $0.034394 0.44%
2-Jan-25 3-Jan-25 17-Jan-25 $0.027266 2.92%
1-Jul-24 2-Jul-24 16-Jul-24 $0.223016 3.21%
2-Jan-24 3-Jan-24 17-Jan-24 $0.026712 0.69%
3-Jan-23 4-Jan-23 18-Jan-23 $0.026198 0.55%
4-Jan-22 5-Jan-22 19-Jan-22 $0.019188 5.70%
1-Jul-21 2-Jul-21 16-Jul-21 $0.349841 5.69%
4-Jan-21 5-Jan-21 19-Jan-21 $0.016602 0.95%
1-Jul-20 2-Jul-20 16-Jul-20 $0.042923 1.13%
2-Jan-20 3-Jan-20 17-Jan-20 $0.024943 0.46%
2-Jan-19 3-Jan-19 17-Jan-19 $0.018694 3.70%
2-Jul-18 3-Jul-18 17-Jul-18 $0.184449 3.78%
2-Jan-18 3-Jan-18 17-Jan-18 $0.01646 0.35%

1 This is the annual distribution return to the end of the relevant distribution date. The distribution return reflects the contribution to total investment return made by the Fund's distributions. Distribution return is calculated as the total return less the growth return. Total return is calculated as the percentage change in a continuing investor's interest in the Fund assuming reinvestment of all distributions back into the Fund (and no other application or withdrawal), net of ongoing fees. Growth return is the Fund's return excluding distributions, net of ongoing fees. Past performance is not indicative of future performance.

Announcements

ASX Announcements: DRUG

Showing - of

Payment notice information

NRWT & fund payments

Document Date
NRWT Fund Payment Notice – June 2026 Distribution 2026-07
NRWT Fund Payment Notice – December 2025 Distribution 2026-01
NRWT and Fund Payment Notice Information – December 2024 Distribution 2025-01
NRWT and Fund Payment Notice information – June 2024 Distribution 2024-07
NRWT and Fund Payment Notice information – December 2023 distributions 2024-01
NRWT and Fund Payment Notice information – December 2022 distributions 2023-01
NRWT and Fund Payment Notice information – December 2021 distributions 2022-06

Resources